Wall Street Associates’s Oxford Immunotec Global OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$341K Hold
22,800
– – 0.23% 157
2016
Q3
$286K Hold
22,800
– – 0.1% 196
2016
Q2
$205K Hold
22,800
– – 0.08% 211
2016
Q1
$226K Hold
22,800
– – 0.09% 213
2015
Q4
$262K Hold
22,800
– – 0.07% 283
2015
Q3
$308K Sell
22,800
-237,300
-91% -$3.22M 0.06% 291
2015
Q2
$3.6M Sell
260,100
-9,000
-3% -$122K 0.34% 103
2015
Q1
$3.79M Buy
269,100
+46,700
+21% +$636K 0.36% 96
2014
Q4
$3.03M Sell
222,400
-8,800
-4% -$120K 0.29% 107
2014
Q3
$3.53M Sell
231,200
-22,000
-9% -$337K 0.36% 101
2014
Q2
$4.26M Buy
253,200
+44,600
+21% +$803K 0.37% 101
2014
Q1
$4.19M Buy
208,600
+30,600
+17% +$662K 0.34% 103
2013
Q4
$3.45M Buy
+178,000
New +$3.15M 0.28% 121

Other funds holding OXFD

Wall Street Associates's OXFD Position: Q4 2016 in Review

Wall Street Associates held its Oxford Immunotec Global (OXFD) position steady in Q4 2016 at 22,800 shares worth $341K. The position accounts for 0.23% of the portfolio, ranked #157.

Wall Street Associates first reported a position in OXFD in Q4 2013 and has held it in 13 quarters since. The position peaked at $4.26M in Q2 2014. 73 funds tracked by Wall St. Rank hold OXFD as of Q4 2016.

  • Wall Street Associates held 22,800 shares of Oxford Immunotec Global worth $341K as of Q4 2016.
  • Wall Street Associates left its Oxford Immunotec Global share count unchanged in Q4 2016.
  • Oxford Immunotec Global made up 0.23% of Wall Street Associates's portfolio in Q4 2016, its #157 holding.
  • Wall Street Associates first reported a position in Oxford Immunotec Global in Q4 2013 and has held it in 13 quarters since.
  • Wall Street Associates's Oxford Immunotec Global position peaked at $4.26M in Q2 2014.
  • 73 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.